✦ LIBER ✦

Targeting Bcl-2 with oblimersen for patients with hormone refractory prostate cancer

✍ Scribed by Kim N. Chi

Publisher: Springer-Verlag
Year: 2005
Tongue: English
Weight: 179 KB
Volume: 23
Category: Article
ISSN: 0724-4983
DOI: 10.1007/s00345-004-0477-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction of Tc2 cells with specificity

Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer

✍ Supriya Perambakam; Bao-Hua Xue; Jeffrey A. Sosman; David J. Peace 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 174 KB

Multimodality treatment in hormone-refra

Multimodality treatment in hormone-refractory prostate cancer patients with bone metastases

✍ Marnix G. E. H. Lam; Bernard A. Zonnenberg 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 75 KB

Intermittent docetaxel therapy with estr

Intermittent docetaxel therapy with estramustine for hormone-refractory prostate cancer in Japanese patients

✍ Norihito Soga; Manabu Kato; Kouhei Nishikawa; Yoshihiro Hasegawa; Yasushi Yamada 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 305 KB

Malignant pericardial tamponade in a pat

Malignant pericardial tamponade in a patient with hormone-refractory prostate cancer

✍ Tomonori Minagawa; Yasushi Murata; Shinichiro Uchikawa; Takeshi Uehara 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 255 KB

Circulating levels of interleukin-6 in p

Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer

✍ Drachenberg, Darrel E.; Elgamal, Abdel-Aziz A.; Rowbotham, Ron; Peterson, Mary; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB 👁 2 views

BACKGROUND. ) is a cytokine that plays a central role in host defense due to its wide range of immune and hematopoietic activities. It is found in high levels in human ejaculate, and has recently been found to regulate prostate-specific protein expression in prostate cancer cells through nonsteroida

Treatment of androgen-independent, hormo

Treatment of androgen-independent, hormone-refractory prostate cancer with docetaxel in Japanese patients

✍ Yasuhide Miyoshi; Hiroji Uemura; Masafumi Nakamura; Hisashi Hasumi; Shinpei Sugi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 210 KB